CH680045A5 - - Google Patents
Download PDFInfo
- Publication number
- CH680045A5 CH680045A5 CH497/90A CH49790A CH680045A5 CH 680045 A5 CH680045 A5 CH 680045A5 CH 497/90 A CH497/90 A CH 497/90A CH 49790 A CH49790 A CH 49790A CH 680045 A5 CH680045 A5 CH 680045A5
- Authority
- CH
- Switzerland
- Prior art keywords
- nctc
- bacterial lysate
- strains
- medicament
- use according
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 16
- 239000006166 lysate Substances 0.000 claims description 16
- 206010012438 Dermatitis atopic Diseases 0.000 claims description 11
- 201000008937 atopic dermatitis Diseases 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 241000588744 Klebsiella pneumoniae subsp. ozaenae Species 0.000 claims description 3
- 241000588653 Neisseria Species 0.000 claims description 3
- 241000191967 Staphylococcus aureus Species 0.000 claims description 3
- 241000193998 Streptococcus pneumoniae Species 0.000 claims description 3
- 241000193996 Streptococcus pyogenes Species 0.000 claims description 3
- 241001312524 Streptococcus viridans Species 0.000 claims description 3
- 241000606768 Haemophilus influenzae Species 0.000 claims description 2
- 241000588655 Moraxella catarrhalis Species 0.000 claims description 2
- 229940079593 drug Drugs 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 229940072221 immunoglobulins Drugs 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- 231100000111 LD50 Toxicity 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 239000004251 Ammonium lactate Substances 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010024438 Lichenification Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 229940059265 ammonium lactate Drugs 0.000 description 1
- 235000019286 ammonium lactate Nutrition 0.000 description 1
- 208000010216 atopic IgE responsiveness Diseases 0.000 description 1
- RZOBLYBZQXQGFY-HSHFZTNMSA-N azanium;(2r)-2-hydroxypropanoate Chemical compound [NH4+].C[C@@H](O)C([O-])=O RZOBLYBZQXQGFY-HSHFZTNMSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000000951 immunodiffusion Effects 0.000 description 1
- 229940099472 immunoglobulin a Drugs 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- LYIRPUGIDGUGRA-UHFFFAOYSA-K trisodium dihydrogen phosphate acetate chloride Chemical compound C(C)(=O)[O-].[Na+].P(=O)([O-])(O)O.[Na+].[Cl-].[Na+] LYIRPUGIDGUGRA-UHFFFAOYSA-K 0.000 description 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH497/90A CH680045A5 (enrdf_load_stackoverflow) | 1990-02-16 | 1990-02-16 | |
| KR1019910002437A KR0169982B1 (ko) | 1990-02-16 | 1991-02-13 | 피부염 치료용 약제 |
| ITMI910381A IT1244743B (it) | 1990-02-16 | 1991-02-14 | Medicamento per il trattamento della dermatite |
| EG9191A EG19540A (en) | 1990-02-16 | 1991-02-14 | Medicament pour le traitement de la dermatite |
| JP3022109A JP3002552B2 (ja) | 1990-02-16 | 1991-02-15 | 皮膚炎治療薬 |
| BE9100144A BE1005589A3 (fr) | 1990-02-16 | 1991-02-15 | Medicament pour le traitement de la dermatite. |
| PT96789A PT96789B (pt) | 1990-02-16 | 1991-02-15 | Processo de preparacao de um medicamento a base de lisados bacterianos |
| DE4104728A DE4104728C2 (de) | 1990-02-16 | 1991-02-15 | Verwendung eines Bakterien-Lysats zur Behandlung der atopischen Dermatitis |
| PL28908491A PL289084A1 (en) | 1990-02-16 | 1991-02-15 | Method of obtaining a pharmaceutical preparation for treating the states of dermatitis |
| FR9102058A FR2658419B1 (fr) | 1990-02-16 | 1991-02-15 | Medicament pour le traitement de la dermatite. |
| GB9103278A GB2240922A (en) | 1990-02-16 | 1991-02-15 | Bacterial lysate for the treatment of dermatitis |
| HU91511A HU210834B (en) | 1990-02-16 | 1991-02-15 | Method for the preparation pharmaceutical composition for the treatment of dermatitis |
| AT0032291A AT402152B (de) | 1990-02-16 | 1991-02-15 | Verwendung eines bakterien-lysats zur herstellung eines medikaments zur behandlung der atopischen dermatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH497/90A CH680045A5 (enrdf_load_stackoverflow) | 1990-02-16 | 1990-02-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH680045A5 true CH680045A5 (enrdf_load_stackoverflow) | 1992-06-15 |
Family
ID=4188357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH497/90A CH680045A5 (enrdf_load_stackoverflow) | 1990-02-16 | 1990-02-16 |
Country Status (13)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2098109C1 (ru) * | 1996-09-26 | 1997-12-10 | Александр Григорьевич Чучалин | Противоаллергическое, противовоспалительное средство, способ его получения, лечебное и косметическое средства с его использованием |
| WO1999048510A1 (fr) * | 1998-03-24 | 1999-09-30 | Tayca Corporation | Inhibiteur de la production d'anticorps d'immunoglobuline m et medicament contre la polyarthrite rhumatoide |
| EP2345421A1 (en) | 2003-06-23 | 2011-07-20 | Biotech Tools S.A. | Epitope composition for sublingual or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin |
| UA72065C2 (en) * | 2004-09-10 | 2005-01-17 | Viridans Ltd Liability Company | Strain aerococcus viridans 167k imb b-7069 with antibacterial activity and "viabac" preparation comprising this strain |
| FR2969657B1 (fr) | 2010-12-22 | 2014-02-07 | Fabre Pierre Dermo Cosmetique | Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie |
| GB201318170D0 (en) * | 2013-10-14 | 2013-11-27 | Univ Edinburgh | Proteins with Diagnostic and Therapeutic Uses |
| EP3960191A4 (en) * | 2019-04-26 | 2023-01-04 | MD Healthcare Inc. | PROTEIN DERIVED FROM STREPTOCOCCUS PYOGENES BACTERIA AND ITS USE |
| KR102437436B1 (ko) | 2019-04-26 | 2022-08-30 | 주식회사 엠디헬스케어 | 스트렙토코커스 파이오제네스 세균 유래 단백질 및 이의 용도 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH633188A5 (fr) * | 1978-05-26 | 1982-11-30 | Om Laboratoires Sa | Medicament contre des maladies infectieuses des voies respiratoires. |
-
1990
- 1990-02-16 CH CH497/90A patent/CH680045A5/fr not_active IP Right Cessation
-
1991
- 1991-02-13 KR KR1019910002437A patent/KR0169982B1/ko not_active Expired - Fee Related
- 1991-02-14 IT ITMI910381A patent/IT1244743B/it active IP Right Grant
- 1991-02-14 EG EG9191A patent/EG19540A/xx active
- 1991-02-15 GB GB9103278A patent/GB2240922A/en not_active Withdrawn
- 1991-02-15 DE DE4104728A patent/DE4104728C2/de not_active Expired - Fee Related
- 1991-02-15 PT PT96789A patent/PT96789B/pt not_active IP Right Cessation
- 1991-02-15 AT AT0032291A patent/AT402152B/de not_active IP Right Cessation
- 1991-02-15 BE BE9100144A patent/BE1005589A3/fr active
- 1991-02-15 HU HU91511A patent/HU210834B/hu not_active IP Right Cessation
- 1991-02-15 PL PL28908491A patent/PL289084A1/xx unknown
- 1991-02-15 FR FR9102058A patent/FR2658419B1/fr not_active Expired - Fee Related
- 1991-02-15 JP JP3022109A patent/JP3002552B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| HU210834B (en) | 1995-08-28 |
| BE1005589A3 (fr) | 1993-11-16 |
| DE4104728A1 (de) | 1991-08-22 |
| FR2658419B1 (fr) | 1995-01-27 |
| ATA32291A (de) | 1996-07-15 |
| KR910015306A (ko) | 1991-09-30 |
| JPH04211017A (ja) | 1992-08-03 |
| GB9103278D0 (en) | 1991-04-03 |
| IT1244743B (it) | 1994-08-08 |
| AT402152B (de) | 1997-02-25 |
| PT96789A (pt) | 1991-10-31 |
| PL289084A1 (en) | 1991-11-04 |
| HUT61201A (en) | 1992-12-28 |
| HU910511D0 (en) | 1991-09-30 |
| DE4104728C2 (de) | 1999-01-14 |
| JP3002552B2 (ja) | 2000-01-24 |
| GB2240922A (en) | 1991-08-21 |
| FR2658419A1 (fr) | 1991-08-23 |
| ITMI910381A1 (it) | 1992-08-14 |
| EG19540A (en) | 1995-08-30 |
| ITMI910381A0 (it) | 1991-02-14 |
| KR0169982B1 (ko) | 1999-02-01 |
| PT96789B (pt) | 1998-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0088303B1 (fr) | Procédé de préparation de complexes polysaccharide-protéine de capsules bactériennes, produits obtenus et compositions immunogènes les contenant | |
| US4382886A (en) | Method for extracting propolis and water soluble dry propolis powder | |
| JPS58172319A (ja) | 治療および診断用組成物 | |
| JPS61112028A (ja) | う蝕予防剤 | |
| WO2004093899A1 (fr) | Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant | |
| FR2522267A1 (fr) | Glycoproteines a activite antitumorale, leur procede de preparation et leur application therapeutique | |
| BE1000967A5 (fr) | Compositions d'anticorps monoclonaux humains assurant la protection croisee. | |
| Yu et al. | Anticariogenic properties of the extract of Cyperus rotundus | |
| BE1005589A3 (fr) | Medicament pour le traitement de la dermatite. | |
| EP0109993A1 (en) | Method for extracting propolis and water soluble dry propolis powder obtained thereby and cosmetic and pharmaceutical preparations containing same | |
| Yu et al. | Asarum sieboldii extracts attenuate growth, acid production, adhesion, and water-insoluble glucan synthesis of Streptococcus mutans | |
| CH720269B1 (fr) | Utilisation d'un composé peptide antibactérien DM80Bu20 dans la préparation d'un dentifrice bactériostatique | |
| FR2499854A1 (fr) | Medicament contenant de la cyclodextrine utile notamment pour provoquer la proliferation des bifidobacteries intestinales | |
| CA2283143A1 (fr) | Composition pharmaceutique ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune | |
| EP0016890A1 (fr) | Nouvelle forme galénique d'administration de la bêtahistine | |
| KR890004103B1 (ko) | 치주염 억제용 항체의 제조방법 | |
| EP1136074B1 (fr) | Procédé d'extraction par un solvant de composés actifs de la chicorée | |
| JPH0641425B2 (ja) | う蝕予防剤 | |
| FR2481927A1 (fr) | Composition anti-allergique et son procede de preparation a partir d'une bacterie lactique du genre streptococcus | |
| FR2550707A1 (fr) | Medicament immunomodulateur d'origine biologique et son procede de preparation | |
| CH633188A5 (fr) | Medicament contre des maladies infectieuses des voies respiratoires. | |
| FR2702655A1 (fr) | Composition thérapeutique nouvelle ayant un effet immunostimulant. | |
| JP2689511B2 (ja) | 食 品 | |
| JP3665850B2 (ja) | 免疫賦活剤 | |
| JPH0255407B2 (enrdf_load_stackoverflow) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |